The phenotype of Vγ9Vδ2 T-cells expanded from healthy donor and cancer patient PBMC using pamidronate, the Vδ2hi-lo bivalent VHH, the various TAA-Vδ2hi-lo bsVHH and TAA-Vδ2hi-lo bsVHH-Fc molecules and the IL-2 control was characterized (representative gating strategy shown in Supplementary Figure S6). The gene discussed is IL2; the disease is cancer.